Effect of Intermittent-Scanning Continuous Glucose Monitoring to Glycemic Control Including Hypoglycemia and Quality of Life of Patients with Type 1 Diabetes Mellitus Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1052180075

Enrollment

104

Registered

2019-02-26

Start date

2019-03-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes mellitus Type 1 diabetes mellitus

Interventions

FreeStyle Libre (flash glucose monitoring device) is used for the intervention. Patients are educated how to use FreeStyle Libre appropriately at the beginning of the intervention. FreeStyle Precisio

Flash glucose monitoring (FGM), education

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Type 1 diabetes mellitus

Exclusion criteria

Exclusion criteria: Pregnant woman

Design outcomes

Primary

Measure	Time frame
Decrease in time in hypoglycemia per day (hour/day)	—

Secondary

Measure	Time frame
Body weight, types of prescribed insulin, total daily dose of prescribed insulin, total daily dose of prescribed basal insulin, frequency of injection of prescribed insulin, glycoalbumin, mean sensor glucose levels, frequency of severe hypoglycemia, indexes for glucose fluctuation [ADRR, MODD, LBGI, TIR(70-180 mg/dl), TAR(>180 mg/dl)], emotional burden of diabetes (PAID), fear of hypoglycemia (HFS), frequency of SMBG (measured), usage of FGM, MARD, MAD, frequency of hypoglycemia per month, hypoglycemia unawareness, index for medical economics (CER, ICER, QALY), severe adverse event (SAE), adverse event (AE).	—

Measure

Time frame

Body weight, types of prescribed insulin, total daily dose of prescribed insulin, total daily dose of prescribed basal insulin, frequency of injection of prescribed insulin, glycoalbumin, mean sensor glucose levels, frequency of severe hypoglycemia, indexes for glucose fluctuation [ADRR, MODD, LBGI, TIR(70-180 mg/dl), TAR(>180 mg/dl)], emotional burden of diabetes (PAID), fear of hypoglycemia (HFS), frequency of SMBG (measured), usage of FGM, MARD, MAD, frequency of hypoglycemia per month, hypoglycemia unawareness, index for medical economics (CER, ICER, QALY), severe adverse event (SAE), adverse event (AE).

—

Contacts

Public ContactTakashi Murata

NHO Kyoto Medical Center

drmurata@nifty.com+81-75-641-9161

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026